Kyprolis (generic: carfilzomib) is a prescription medication used to treat multiple myeloma (bone marrow cancer) in adults.  Kyprolis belongs to a group of drugs called proteasome inhibitors, which stop or slow the growth of cancer cells.

This medication comes in an injectable form and is given directly into a vein (IV) by a healthcare provider. It is usually given 2 days in a row each week, for 3 weeks.

Common side effects of Kyprolis include tiredness, anemia, and nausea.